Novel targeted drug shows promise against advanced small cell lung cancer

Posted by on June 5, 2016 4:41 pm
Categories: health

The experimental “smart-bomb” drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer, according to results from a first-in-human clinical trial.

Leave a Reply

Your email address will not be published. Required fields are marked *